📊 GRDX Key Takeaways
Is GRDX a Good Investment? Thesis Analysis
GridAI Technologies faces severe financial distress with only $403K in revenue while burning $1.7M in annual operating cash flow, leaving less than 18 months of cash runway at current burn rates. The company exhibits massive operating losses (net margin of -846,327%), negative free cash flow, and provides no evidence of viable commercialization or clear path to profitability in the pharmaceutical sector.
GridAI Technologies shows negligible revenue and deeply negative operating and net margins, consistent with a pre-commercial stage and ongoing losses. Liquidity is acceptable and leverage is modest, but limited cash alongside persistent operating cash burn and negative interest coverage imply reliance on external financing. Until durable revenue traction and a meaningful reduction in cash burn are evident, fundamentals skew unfavorably.
Why Buy GRDX? Key Strengths
- Conservative leverage with 0.23x Debt/Equity ratio
- Adequate current liquidity ratio of 2.62x providing short-term flexibility
- Reasonable asset base of $135.4M suggesting retained capital from prior financing
- Solid short-term liquidity (current/quick ratio ~2.6x)
- Modest leverage (0.23x D/E) reduces insolvency risk
- Low capital intensity (minimal capex) provides flexibility
GRDX Investment Risks to Consider
- Critical cash runway of less than 18 months at current burn rate with only $2.5M cash on hand
- Operating losses of $2.4M annually with no revenue traction to offset costs
- Negative free cash flow of $1.8M indicates cash depletion, likely requiring dilutive equity financing or strategic alternatives
- Minimal revenue with extreme negative margins and losses
- Negative operating cash flow and low cash balance create runway risk
- Negative interest coverage and likely dependence on dilutive financing
Key Metrics to Watch
- Monthly cash burn rate and runway remaining
- Quarterly revenue growth and product commercialization progress
- Operating cash flow trajectory toward profitability
- Cash & equivalents
- Operating cash flow (TTM)
GRDX Financial Metrics
💡 AI Analyst Insight
Strong liquidity with a 2.62x current ratio provides a solid financial cushion.
GRDX Profitability Ratios
GRDX vs Healthcare Sector
How GridAI Technologies Corp. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is GRDX Overvalued or Undervalued?
Based on fundamental analysis, GridAI Technologies Corp. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
GRDX Balance Sheet & Liquidity
GRDX 5-Year Financial Trend & Growth Analysis
5-Year Trend Summary: GridAI Technologies Corp.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-47.88 indicates the company is currently unprofitable.
GRDX Growth Metrics (YoY)
GRDX Capital Allocation
GRDX SEC 10-K & 10-Q Filing Analysis
Access official SEC EDGAR filings for GridAI Technologies Corp. (CIK: 0001604191)
📋 Recent SEC Filings
❓ Frequently Asked Questions about GRDX
What is the AI rating for GRDX?
GridAI Technologies Corp. (GRDX) has a Combined AI Rating of SELL from Claude (STRONG SELL) and ChatGPT (SELL) with 79% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are GRDX's key strengths?
Claude: Conservative leverage with 0.23x Debt/Equity ratio. Adequate current liquidity ratio of 2.62x providing short-term flexibility. ChatGPT: Solid short-term liquidity (current/quick ratio ~2.6x). Modest leverage (0.23x D/E) reduces insolvency risk.
What are the risks of investing in GRDX?
Claude: Critical cash runway of less than 18 months at current burn rate with only $2.5M cash on hand. Operating losses of $2.4M annually with no revenue traction to offset costs. ChatGPT: Minimal revenue with extreme negative margins and losses. Negative operating cash flow and low cash balance create runway risk.
What is GRDX's revenue and growth?
GridAI Technologies Corp. reported revenue of $403.0.
Does GRDX pay dividends?
GridAI Technologies Corp. does not currently pay dividends.
Where can I find GRDX SEC filings?
Official SEC filings for GridAI Technologies Corp. (CIK: 0001604191) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is GRDX's EPS?
GridAI Technologies Corp. has a diluted EPS of $-2.28.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is GRDX a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, GridAI Technologies Corp. has a SELL rating with 79% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is GRDX stock overvalued or undervalued?
Valuation metrics for GRDX: ROE of -12.2% (sector avg: 15%), net margin of -846,327.5% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy GRDX stock in 2026?
Our dual AI analysis gives GridAI Technologies Corp. a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is GRDX's free cash flow?
GridAI Technologies Corp.'s operating cash flow is $-1.7M, with capital expenditures of $69.5K. FCF margin is -446,324.8%.
How does GRDX compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -846,327.5% (avg: 12%), ROE -12.2% (avg: 15%), current ratio 2.62 (avg: 2).